E-LIB Suche - Ergebnisse für: Galien, Rene

1

Discovery of GLPG3667, a Selective ATP Competitive Tyrosine..:

Mammoliti, Oscar ; Martina, Sébastien ; Claes, Pieter...
Journal of Medicinal Chemistry. 67 (2024) 11 - p. 8545-8568 , 2024

Link: https://doi.org/10.1021/..

2

Mucosal p-STAT1/3 correlates with histologic disease activi..:

Reinisch, Walter ; Serone, Adrian ; Hébuterne, Xavier...
Tissue Barriers. 11 (2022) 2 - p. , 2022

Link: https://doi.org/10.1080/..

3

JAK selectivity and the implications for clinical inhibitio..:

Traves, Paqui G ; Murray, Bernard ; Campigotto, Federico...
Annals of the Rheumatic Diseases. 80 (2021) 7 - p. 865-875 , 2021

Link: https://doi.org/10.1136/..

4

Effects of JAK1-Preferential Inhibitor Filgotinib on Circul..:

Roblin, Xavier ; Serone, Adrian ; Yoon, Oh Kyu...
Inflammatory Bowel Diseases. 28 (2021) 8 - p. 1207-1218 , 2021

Link: https://doi.org/10.1093/..

5

Tu1880 EFFECTS OF THE JANUS KINASE (JAK1)-SELECTIVE INHIBIT..:

Roblin, Xavier ; Serone, Adrian ; Yoon, Oh Kyu...
Gastroenterology. 158 (2020) 6 - p. S-1201-S-1202 , 2020

Link: https://doi.org/10.1016/..

6

Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Bio..:

Tarrant, Jacqueline M. ; Galien, René ; Li, Wanying...
Rheumatology and Therapy. 7 (2020) 1 - p. 173-190 , 2020

Link: https://doi.org/10.1007/..

7

Tu1878 FILGOTINIB DECREASES MOLECULAR MARKERS OF JAK1 SIGNA..:

Reinisch, Walter ; Brodbeck, Jens ; Galien, Rene...
Gastroenterology. 158 (2020) 6 - p. S-1200-S-1201 , 2020

Link: https://doi.org/10.1016/..

8

O02 The JAK1-selective inhibitor filgotinib reverses the di..:

Taylor, Peter ; Downie, Bryan ; Zhuo, Luting...
Rheumatology. 58 (2019) Supplement_3 - p. , 2019

Link: https://doi.org/10.1093/..

9

Sa1757 - Filgotinib Decreases Systemic and Mucosal Markers ..:

Sandborn, William J. ; Feagan, Brian G. ; Galien, Rene...
Gastroenterology. 154 (2018) 6 - p. S-383 , 2018

Link: https://doi.org/10.1016/..

10

Correction to Discovery, Structure–Activity Relationship, a..:

Joncour, Agnès ; Desroy, Nicolas ; Housseman, Christopher...
Journal of Medicinal Chemistry. 61 (2018) 9 - p. 4270-4270 , 2018

Link: https://doi.org/10.1021/..

11

Discovery, Structure–Activity Relationship, and Binding Mod..:

Joncour, Agnès ; Desroy, Nicolas ; Housseman, Christopher...
Journal of Medicinal Chemistry. 60 (2017) 17 - p. 7371-7392 , 2017

Link: https://doi.org/10.1021/..

12

Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of..:

Vanhoutte, Frédéric ; Mazur, Minodora ; Voloshyn, Oleksandr...
Arthritis & Rheumatology. 69 (2017) 10 - p. 1949-1959 , 2017

Link: https://doi.org/10.1002/..

13

Filgotinib (GLPG0634, GS-6034), a JAK-1 Selective Inhibitor..:

Sandborn, William J. ; Feagan, Brian G. ; De Hertogh, Gert...
Gastroenterology. 152 (2017) 5 - p. S602 , 2017

Link: https://doi.org/10.1016/..

14

Safety, pharmacokinetics and pharmacodynamics of GLPG0974, ..:

Namour, Florence ; Galien, René ; Van Kaem, Tim...
British Journal of Clinical Pharmacology. 82 (2016) 1 - p. 139-148 , 2016

Link: https://doi.org/10.1111/..

15

Janus kinases in inflammatory bowel disease: Four kinases f..:

Galien, René
Pharmacological Reports. 68 (2016) 4 - p. 789-796 , 2016

Link: https://doi.org/10.1016/..